AIM IMMUNOTECH INC.

AIM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G May 27, 2026
8-K May 21, 2026 8-K
424B5 May 21, 2026 424B5
424B5 May 19, 2026 424B5
8-K May 19, 2026 8-K
10-Q May 15, 2026 10-Q
8-K May 14, 2026 8-K
SCHEDULE 13G May 12, 2026
8-K May 12, 2026 8-K
8-K May 8, 2026 8-K
8-K Apr 10, 2026 8-K
424B5 Apr 10, 2026 424B5
10-K Mar 27, 2026 10-K
4 Mar 16, 2026 4
4 Mar 16, 2026 4
4 Mar 10, 2026 4
4 Mar 10, 2026 4
8-K Mar 6, 2026 8-K
424B3 Feb 27, 2026 424B3
424B4 Feb 17, 2026 424B4
EFFECT Feb 10, 2026
S-1/A Feb 10, 2026 S-1/A
4 Feb 6, 2026 4
CORRESP Feb 6, 2026
8-K Feb 5, 2026 8-K
← Newer Page 2 of 63 · 1567 filings Older →